Just Released: "Proplex Technologies, Llc - Product Pipeline Analysis, 2013 Update"

Proplex Technologies, LLC (Proplex) is a biotechnology company. The company discovers biomarkers in human diseases. It conducts biotechnology research and experimental development in human diseases. The company uses its 2D HPLE technology, a conventional two-dimensional polyacrylamide gel electrophoresis, invented by the company. Proplex technology has identified over 40 novel short peptide biomarkers in several cancers. It concentrates on validating biomarkers to address the high unmet medical needs in managing cancer diagnosis and therapy. The company also developed serum GASP-1 ELISA to monitor the effectiveness of a therapeutic treatment.

Full Report Details at
- http://www.fastmr.com/prod/756753_proplex_technologies_llc_product_pipeline.aspx?afid=303

This report is a source for data, analysis and actionable intelligence on the Proplex Technologies, Llc portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
* Design and develop your product development, marketing and sales strategies.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Tissue Regeneration Technologies, LLC - Product Pipeline Analysis, 2013 Update
- Autoimmune Technologies, LLC - Product Pipeline Analysis, 2013 Update
- AnalizaDx, LLC - Product Pipeline Analysis, 2013 Update
- Redyns Medical, LLC - Product Pipeline Analysis, 2013 Update
- Innovia LLC - Product Pipeline Analysis, 2013 Update